全文获取类型
收费全文 | 45574篇 |
免费 | 3275篇 |
国内免费 | 160篇 |
专业分类
耳鼻咽喉 | 663篇 |
儿科学 | 1214篇 |
妇产科学 | 790篇 |
基础医学 | 6001篇 |
口腔科学 | 579篇 |
临床医学 | 4680篇 |
内科学 | 9629篇 |
皮肤病学 | 491篇 |
神经病学 | 4378篇 |
特种医学 | 1670篇 |
外科学 | 7571篇 |
综合类 | 839篇 |
现状与发展 | 1篇 |
一般理论 | 40篇 |
预防医学 | 3571篇 |
眼科学 | 588篇 |
药学 | 3107篇 |
中国医学 | 58篇 |
肿瘤学 | 3139篇 |
出版年
2023年 | 268篇 |
2022年 | 510篇 |
2021年 | 1164篇 |
2020年 | 658篇 |
2019年 | 1073篇 |
2018年 | 1296篇 |
2017年 | 871篇 |
2016年 | 1021篇 |
2015年 | 1237篇 |
2014年 | 1630篇 |
2013年 | 2161篇 |
2012年 | 3598篇 |
2011年 | 3666篇 |
2010年 | 2034篇 |
2009年 | 1823篇 |
2008年 | 3050篇 |
2007年 | 3124篇 |
2006年 | 3046篇 |
2005年 | 3084篇 |
2004年 | 2752篇 |
2003年 | 2606篇 |
2002年 | 2362篇 |
2001年 | 401篇 |
2000年 | 281篇 |
1999年 | 380篇 |
1998年 | 487篇 |
1997年 | 423篇 |
1996年 | 347篇 |
1995年 | 335篇 |
1994年 | 289篇 |
1993年 | 263篇 |
1992年 | 232篇 |
1991年 | 199篇 |
1990年 | 180篇 |
1989年 | 171篇 |
1988年 | 161篇 |
1987年 | 137篇 |
1986年 | 129篇 |
1985年 | 122篇 |
1984年 | 135篇 |
1983年 | 113篇 |
1982年 | 146篇 |
1981年 | 152篇 |
1980年 | 106篇 |
1979年 | 74篇 |
1978年 | 72篇 |
1977年 | 71篇 |
1976年 | 60篇 |
1975年 | 54篇 |
1973年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
991.
King LA Nogareda F Weill FX Mariani-Kurkdjian P Loukiadis E Gault G Jourdan-DaSilva N Bingen E Macé M Thevenot D Ong N Castor C No?l H Van Cauteren D Charron M Vaillant V Aldabe B Goulet V Delmas G Couturier E Le Strat Y Combe C Delmas Y Terrier F Vendrely B Rolland P de Valk H 《Clinical infectious diseases》2012,54(11):1588-1594
992.
Pegylated Interferon alfa (PEG-IFN) is the only licensed agent that allows a sustained virologic response in a subset group of patients with chronic hepatitis B, both e antigen (HBeAg)-positive and negative, after a finite course of therapy. Despite this major advantage, its use is limited because of its lack of efficacy in a large proportion of patients and a high relapse rate especially in HBeAg-negative patients. Baseline host and viral factors have been largely used to identify candidates for PEG-IFN therapy in the pre-treatment phase, but they have failed to translate into a clear therapeutic choice because of their low predictability. Recently, the use of HBeAg and especially hepatitis B surface antigen (HBsAg) as quantitative serological markers, has led to a revolution in the management of this disease by introducing a new concept of on-treatment prediction of response and stopping rules as early as week 12 of therapy. 相似文献
993.
994.
Sundaramurthy Srilekha SelvaKumar Ambika Ching Jared Dharani Vidhya Sarangapani Sripriya Yu-Wai-Man Patrick 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2021,259(9):2461-2472
Graefe's Archive for Clinical and Experimental Ophthalmology - Leber hereditary optic neuropathy (LHON) is the most common primary mitochondrial DNA (mtDNA) disorder with the majority of... 相似文献
995.
996.
997.
998.
999.
When the internal texture of a Gabor patch moves orthogonally to its envelope''s motion, the perceived path, viewed in the periphery, shifts dramatically in position, and direction relative to the true path (the double-drift illusion). Here, we examine positional uncertainty as a critical factor underlying this illusory shift. We presented participants with an anchoring line at different distances from the drifting Gabor''s physical path. Our results indicate that placing an anchor (a fixed line) close to the Gabor''s path halved the magnitude of the illusion. This suppression was symmetrical for anchors placed on either side of the Gabor. In a second experiment, we used crowding to degrade the anchoring line''s position information by embedding it in a set of parallel lines. In this case, despite the presence of the same lines that reduced the illusion when presented in isolation, the illusory shift was now largely restored. We suggest that the adjacent lines crowded each other, reducing their positional certainty, and thus their ability to anchor the location of the moving Gabor. These findings indicate that the positional uncertainty of the equiluminant Gabor patch is critical for the illusory position offset. 相似文献
1000.
David P. Goldstein MD Gideon Y. Bachar MD Jane Lea MD Mark G. Shrime MD Rajan S. Patel MB Patrick J. Gullane MB Dale H. Brown MB Ralph W. Gilbert MD John Kim MD Jonathan Waldron MD Bayardo Perez–Ordonez MD Aileen M. Davis PhD Lu Cheng MMath Wei Xu PhD Jonathan C. Irish MD 《Head & neck》2013,35(5):632-641